PARADIGM is a public-private partnership and is co-led by the European Patients’ Forum and EFPIA.
PARADIGM’s mission is to provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players.
The objective is to develop much needed processes and tools for three key decision-making points: research priority setting, design of clinical trials and early dialogue. Building on advances at international level, PARADIGM will integrate the needs, perspectives and expectations of all actors (including vulnerable populations) involved and will also produce a set of metrics to measure the impact of patient engagement.
Project objectives
Needs and expectations
Strengthen the understanding of stakeholders’ needs and expectations for engagement (including underrepresented and vulnerable populations);
Sustainability roadmap
Develop an inventive and workable sustainability roadmap to optimise patient engagement in key decision-making points across medicines’ R&D;
Maximum synergies
Ensure maximum synergies with other initiatives focusing on the patient’s voice in the life cycle of medicines, like Patient Focussed Medicines Development (PFMD) or the European Patient Academy on Therapeutic Innovation (EUPATI).
Agreed metrics
Develop agreed patient engagement metrics to increase evidence demonstrating the impact of patient engagement practices;
Systems-readiness
Strengthen systems-readiness towards patient engagement across the diverse range of stakeholders that develop, regulate and assess medicines;
Start date of the project: 01.03.2018 / End date of the project: 31.08.2020